Yalcın B - Search Results

1

Radiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle ınvasive bladder cancer.

Demirci U, Dızdar O, Cetindag MF, Altınova S, Ozsavran A, Dede DS, Kızılırmak N, Eraslan FA, Yalcın B, Cinkir HY. Demirci U, et al. Among authors: yalcin b. J Cancer Res Ther. 2015 Oct-Dec;11(4):704-7. doi: 10.4103/0973-1482.147381. J Cancer Res Ther. 2015. PMID: 26881505 Free article.

2

Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma.

Utkan G, Büyükçelik A, Yalçin B, Akbulut H, Demirkazik A, Dinçol D, Onur H, Gören D, Mousa U, Senler FC, Içli F. Utkan G, et al. Among authors: yalcin b. Lung Cancer. 2006 Sep;53(3):367-74. doi: 10.1016/j.lungcan.2006.04.014. Epub 2006 Jul 7. Lung Cancer. 2006. PMID: 16828196 Clinical Trial.

3

Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer.

Icli F, Akbulut H, Utkan G, Yalcin B, Dincol D, Isikdogan A, Demirkazik A, Onur H, Cay F, Büyükcelik A. Icli F, et al. Among authors: yalcin b. J Surg Oncol. 2007 May 1;95(6):507-12. doi: 10.1002/jso.20728. J Surg Oncol. 2007. PMID: 17192920 Clinical Trial.

4

Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer.

Karacetin D, Yalcin B, Okten B, Ozturk S, Maral O, Incekara O. Karacetin D, et al. Among authors: yalcin b. J BUON. 2009 Oct-Dec;14(4):605-8. J BUON. 2009. PMID: 20148449 Clinical Trial.

5

Concomitant temozolomide and radiotherapy versus radiotherapy alone for treatment of newly diagnosed glioblastoma multiforme.

Karacetin D, Okten B, Yalcin B, Incekara O. Karacetin D, et al. Among authors: yalcin b. J BUON. 2011 Jan-Mar;16(1):133-7. J BUON. 2011. PMID: 21674864

6

Non-metastatic upper tract transitional cell carcinoma: single center experience.

Demirci U, Canda AE, Dede DS, Cakici OU, Akinci MB, Yalcin B. Demirci U, et al. Among authors: yalcin b. Asian Pac J Cancer Prev. 2013;14(2):1131-2. doi: 10.7314/apjcp.2013.14.2.1131. Asian Pac J Cancer Prev. 2013. PMID: 23621200 Free article.

7

End-of-study results of Turkish gastric cancer patients from the global REGATE study.

Yalcin S, Gumus M, Kilickap S, Alkis N, Ilhan M, Oksuzoglu B, Orhan B, Unsal M, Basol Tekin S, Yalcin B, Demir G. Yalcin S, et al. Among authors: yalcin b. J BUON. 2014 Apr-Jun;19(2):377-87. J BUON. 2014. PMID: 24965395 Free article.

8

Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.

Ozdemir N, Abali H, Vural M, Yalcin S, Oksuzoglu B, Civelek B, Oguz D, Bostanci B, Yalcin B, Zengin N. Ozdemir N, et al. Among authors: yalcin b, yalcin s. Cancer Chemother Pharmacol. 2014 Dec;74(6):1139-47. doi: 10.1007/s00280-014-2586-6. Epub 2014 Sep 19. Cancer Chemother Pharmacol. 2014. PMID: 25234436 Clinical Trial.

9

Expectations of response from octreotide therapy in recurrent phosphaturic mesenchymal tumors--do they reflect reality?

Ulas A, Dede DS, Sendur MA, Akinci MB, Yalcin B. Ulas A, et al. Among authors: yalcin b. Asian Pac J Cancer Prev. 2014;15(24):10997-8. doi: 10.7314/apjcp.2014.15.24.10997. Asian Pac J Cancer Prev. 2014. PMID: 25605218 Free article. No abstract available.

10

Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer.

Şendur MA, Aksoy S, Akıncı MB, Ozdemir N, Dede DŞ, Altundag K, Zengin N, Yalçın B. Şendur MA, et al. Among authors: yalcin b. Future Oncol. 2015;11(6):905-7. doi: 10.2217/fon.15.6. Future Oncol. 2015. PMID: 25760972 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

602 results

Search Page

Filters